SEC FORM 4
$310,932.12
GeneDx Holdings Corp. (WGS)
Sale of 3,692 shares at $84.2178 per share.
Reporting Person Stueland Katherine · Officer Title CHIEF EXECUTIVE OFFICER · Transaction Code S
Traded Sep 9, 2026 · Disclosed Sep 11, 2026
Source: SEC Form 4 · 0001689575-26-000030 · filed 2026-09-11 · View filing →